Literature DB >> 9857001

Characterization of c-myc 3' to 5' mRNA decay activities in an in vitro system.

G Brewer1.   

Abstract

The levels of mRNA and protein encoded by the c-myc protooncogene set the balance between proliferation and differentiation of mammalian cells. Thus, it is essential for the cell to tightly control c-myc expression. Indeed, cells utilize many mechanisms to control c-myc expression, including transcription, RNA processing, translation, and protein stability. We have focused on turnover of c-myc mRNA as a key modulator of the timing and level of c-myc expression. c-myc mRNA is labile in cells, and its half-life is controlled by multiple instability elements located within both the coding region and the 3'-untranslated region (3'-UTR). Much work has focused on the protein factors that bind the instability elements, yet little is known about the enzymatic activities that effect the degradation of c-myc mRNA. Here I have utilized a novel cell-free mRNA decay system to characterize the c-myc mRNA decay machinery. This machinery consists of 3' to 5' mRNA decay activities that are Mg2+-dependent, require neither exogenous ATP/GTP nor an ATP-regenerating system, and act independently of a 7mG(5')ppp(5')G cap structure to deadenylate an exogenous mRNA substrate in a c-myc 3'-UTR-dependent fashion. Following deadenylation, nucleolytic decay of the 3'-UTR occurs generating 3' decay intermediates via a ribonucleolytic activity that can assemble on the c-myc 3'-UTR in a poly(A)-independent manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857001     DOI: 10.1074/jbc.273.52.34770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Identification of an erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage.

Authors:  Z Wang; M Kiledjian
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Zygotic regulation of maternal cyclin A1 and B2 mRNAs.

Authors:  Y Audic; C Anderson; R Bhatty; R S Hartley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  The identification of an endonuclease that cleaves within an HuR binding site in mRNA.

Authors:  Z Zhao; F C Chang; H M Furneaux
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

4.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 5.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 6.  Tristetraprolin: roles in cancer and senescence.

Authors:  Christina R Ross; Sarah E Brennan-Laun; Gerald M Wilson
Journal:  Ageing Res Rev       Date:  2012-02-24       Impact factor: 10.895

7.  A fluorescence-based assay for 3' --> 5' exoribonucleases: potential applications to the study of mRNA decay.

Authors:  G M Wilson; H Lu; Y Sun; A Kennedy; G Brewer
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

8.  RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.

Authors:  H Tourrière; I E Gallouzi; K Chebli; J P Capony; J Mouaikel; P van der Geer; J Tazi
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Poly(A)-binding-protein-mediated regulation of hDcp2 decapping in vitro.

Authors:  Richie Khanna; Megerditch Kiledjian
Journal:  EMBO J       Date:  2004-04-15       Impact factor: 11.598

10.  The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci.

Authors:  Dierk Ingelfinger; Donna J Arndt-Jovin; Reinhard Lührmann; Tilmann Achsel
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.